Market Place
Sourcing Support
Castle Creek Pharmaceutical Holdings Completes Acquisition of Fibrocell Science
13 Dec 2019 //
PRESS RELEASE
Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell
14 Sep 2019 //
BIOSPACE
Castle Creek Pharma Receives $71.8m in Funding
24 Oct 2018 //
FINSMES
Fresh from $72M raise, New lead rare disease drug flagged as failure
23 Oct 2018 //
ENDPTS
Castle Creek Pharmaceuticals Receives FDA FT Designatn for Diacerein 1% Ointment
09 Aug 2018 //
PR NEWSWIRE
FogPharma Secures $66 Million Series B Financing
16 May 2018 //
PR NEWSWIRE
Castle Creek Pharmaceuticals Receives FDA Rare Pediatric Disease Designation
16 May 2018 //
PR NEWSWIRE
TWi Biotechnology Inc. Reports Positive Interim Results from AC-201 CR
24 Dec 2015 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.